Portage Biotech (Portage Biotech) Operating Cash Flow per Share : $-0.63 (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Portage Biotech Operating Cash Flow per Share?

Portage Biotech's operating cash flow per share for the three months ended in Dec. 2023 was $-0.16. Portage Biotech's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.63.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -30.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -20.20% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 14.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Portage Biotech's Operating Cash Flow per Share or its related term are showing as below:

PRTG' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -42.8 Med: 25.9 Max: 58.2
Current: -30.2

During the past 13 years, Portage Biotech's highest 3-Year average Operating Cash Flow per Share Growth Rate was 58.20% per year. The lowest was -42.80% per year. And the median was 25.90% per year.

PRTG's 3-Year OCF Growth Rate is ranked worse than
80.96% of 1234 companies
in the Biotechnology industry
Industry Median: 3.5 vs PRTG: -30.20

Portage Biotech Operating Cash Flow per Share Historical Data

The historical data trend for Portage Biotech's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Portage Biotech Operating Cash Flow per Share Chart

Portage Biotech Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.18

-0.34

-0.37

-0.52

-0.75

Portage Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.16	-0.27	-0.20	-	-0.16

Competitive Comparison of Portage Biotech's Operating Cash Flow per Share

For the Biotechnology subindustry, Portage Biotech's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Portage Biotech's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Portage Biotech's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Portage Biotech's Price-to-Operating-Cash-Flow falls into.

Portage Biotech Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Portage Biotech's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (A: Mar. 2023 )	=	Cash Flow from Operations (A: Mar. 2023 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2023 )
	=	-12.073	/	16.119
	=	-0.75

Portage Biotech's Operating Cash Flow per Share for the quarter that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-3.431	/	20.897
	=	-0.16

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.63

Portage Biotech Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Portage Biotech's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Portage Biotech (Portage Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Portage Biotech Inc (NAS:PRTG) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Clarence Thomas Building, P.O. Box 4649, Tortola, Road Town, VGB, VG1110

Website

https://www.portagebiotech.com

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.